No abstract

Bioinert ceramics have been commonly used in the field of orthopedic and dentistry due to their excellent mechanical properties, esthetic look, good biocompatibility and chemical inertness. However, an activation of its bioinert surface could bring additional advantages for better implant-integration in vivo. Therefore, we introduce an innovative biomimetic co-precipitation technique by using modified simulated body fluid (SBF) to obtain a composite coating made of organic/non-organic components. The zirconia samples were soaked in SBF containing different concentrations of protein (0.01, 0.1, 1, 10 and 100 g/l). Bovine serum albumin (BSA) was applied as a standard protein. During the soaking time, a precipitation of calcium phosphate took place on the substrate surfaces. The proteins were incorporated into the coating during precipitation. Morphology changes of precipitated hydroxyapatite (HAp) due to the presence of proteins were observed on SEM-images. The presence of proteins within the coating was proven by using SEM/energy dispersive X-ray spectroscopy (EDX) and immunohistochemical analysis. We conclude that it is possible to co-precipitate the organic/non-organic composite on inert ceramic by using the wet-chemistry method. In future studies, BSA could be replaced by targeted proteins appropriate to the application area. This method could create new biomaterials, the surfaces of which could be tailored according to the desires and requirements of their use.

Aseptic loosening and periprosthetic infections are complications that can occur at the interface between inert ceramic implants and natural body tissues. Therefore, the need for novel materials with antibacterial properties to prevent implant-related infection is evident. This study proposes multifunctionalizing the inert ceramic implant surface by biomimetic calcium phosphate (CaP) coating decorated with antibiotic-loaded nanoparticles for bioactivity enhancement and antibacterial effect. This study aimed to coat zirconium dioxide (ZrO2) substrates with a bioactive CaP-layer containing drug-loaded degradable polymer nanoparticles (NPs). The NPs were loaded with two antibiotics, gentamicin or bacitracin. The immobilization of NPs happened by two deposition methods: coprecipitation and drop-casting. X-ray diffraction (XRD), scanning electron microscopy (SEM), and cross-section analyses were used to characterize the coatings. MG-63 osteoblast-like cells and human mesenchymal stem cells (hMSC) were chosen for in vitro tests. Antibacterial activity was assessed with S. aureus and E. coli. The coprecipitation method allowed for a favorable homogeneous distribution of the NPs within the CaP coating. The CaP coating was constituted of hydroxyapatite and octacalcium phosphate; its thickness was 3.8 ± 1 μm with cavities of around 1 μm suitable for hosting NPs with a size of 200 nm. Antibiotics were released from the coatings in a controlled manner for 1 month. The cell culture study has confirmed the excellent behavior of the coprecipitated coating, showing cytocompatibility and a homogeneous distribution of the cells on the coated surfaces. The increase in alkaline phosphatase activity showed osteogenic differentiation. The materials were found to inhibit the growth of bacteria. Newly developed coatings with antibacterial and bioactive properties are promising candidates to prevent peri-implant infectious bone diseases.